About Us
Clinilabs is a global, full-service CRO focused exclusively on CNS drug, device, and technology development. With deep expertise in CNS, Clinilabs is committed to developing therapies that address a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS disorders. Clinilabs partners with pharmaceutical, biotechnology, and medical device companies to provide a comprehensive spectrum of high-quality, timely, and cost-effective clinical drug development services from first-in-human to Phase 3 trials, all aimed at accelerating the development of new CNS therapies. Since 2000, Clinilabs has conducted more than 750 CNS clinical trials and has been instrumental in the approval of 22 new therapies across 13 CNS indications, significantly impacting the lives of patients worldwide.
Our Mission
Clinilabs’ mission is to provide high-quality, prompt, and cost-effective drug and device development services to its clients in the interest of delivering new therapeutics to those in need.
Our Vision
Clinilabs’ vision is to become the leading contract research organization (CRO) dedicated to providing CNS clinical development services.
Our Culture
Clinilabs aspires to a “culture of quality” in which all our decisions and actions represent our dedication to quality in clinical development and health care.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
All truths are easy to understand once they are discovered; the point is to discover them.
The reward for work well done is the opportunity to do more.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
If you think compliance is expensive, try non-compliance.
One never notices what has been done; one can only see what remains to be done.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
I am not accustomed to saying anything with certainty after only one or two observations.
The pace of discovery is going unbelievably fast.
Good information is the best medicine.
I have no ideology. My ideology is health.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
Drugs don’t work in patients who don’t take them.
One sometimes finds what one is not looking for.
There is so much more to be done; the patients are waiting.
The best way to predict the future is to invent it.